NXT Nutritionals Appoints Leading Diabetes Expert Camillo Ricordi, M.D., to Its Medical Advisory Board
December 09 2010 - 9:00AM
Business Wire
NXT Nutritionals Holdings, Inc. (“NXT Nutritionals”) (OTCBB:
NXTH.OB), developer and marketer of SUSTA™ Natural Sweetener, the
great-tasting, all-natural and healthier sweetener, today announced
the appointment of Camillo Ricordi M.D., the Director and Chief
Academic Officer of the Diabetes Research Institute of the
University of Miami, to its Medical Advisory Board. In his new role
at NXT Nutritionals, Dr. Ricordi will support the Company’s efforts
to inform people with diabetes about SUSTA, the healthy alternative
to sugar and artificial sweeteners.
“We are honored to welcome Dr. Ricordi to our Medical Advisory
Board, and are confident that his background and experience in
diabetes research will prove invaluable to the Company,” said
Michael McCarthy, president and CEO of NXT Nutritionals. “Dr.
Ricordi has earned the highest honors in his field, and we look
forward to working with him on initiatives designed especially for
people with diabetes and people eager to remove excess sugars from
their diets.”
A leading expert in pancreatic islet transplantation, Dr.
Ricordi is the Stacy Joy Goodman Professor of Surgery,
Distinguished Professor of Medicine, Professor of Biomedical
Engineering, and Microbiology and Immunology at the University of
Miami Diabetes Research Institute. He also serves as Director of
the Diabetes Research Institute Cell Transplant Center and
Responsible Head of the cGMP Human Cell Processing Facility, a
NIH-funded facility.
“I am pleased to be joining NXT Nutritionals’ Medical Advisory
Board to help consumers learn about SUSTA, a groundbreaking,
all-natural sugar alternative that is safe for people with
diabetes,” said Dr. Ricordi. “The Company understands the
importance of presenting alternatives to dietary sugars in order to
begin to curb the country’s burgeoning diabetes epidemic, and I am
thrilled to be a part of their efforts.”
Among his many accomplishments, Dr. Ricordi has served as
President of the Cell Transplant Society, Co-founder and Chairman
of the National Diabetes Research Coalition, Co-founder and
President of the International Association for Pancreas and Islet
Transplantation and a member of the council of The Transplantation
Society. He has authored over 600 scientific publications and has
been awarded 11 patents as an inventor. Dr. Ricordi completed his
graduate and post-graduate studies at the University of Milan,
Italy and Università degli Studi di Milano.
About NXT Nutritionals Holdings, Inc.
Headquartered in Holyoke, MA, NXT Nutritionals Holdings, Inc.,
through its wholly owned subsidiary NXT Nutritionals, Inc., is a
developer and marketer of a proprietary, patent-pending,
all–natural, healthy sweetener sold under the brand name SUSTA™ and
other food and beverage products. SUSTA™ Natural Sweetener, sold as
a stand-alone product and the common ingredient for all of the
Company’s products, is an all-natural, healthy sweetener that has
minimal calories and low glycemic index. NXT Nutritionals has also
developed a line of SUSTA™-enhanced best-in-class, non-fat
reduced-calorie yogurt smoothies that are marketed as Healthy
Dairy® Yogurt Smoothies. For additional information, please visit
NXT Nutritionals’ corporate website:
www.nxtnutritionals.com
Forward-Looking Statements
The statements in the press release that relate to the Company's
expectations with regard to the future impact on the Company's
results from new products in development are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements are subject to risks and
uncertainties. Words such as "expects", "intends", "plans", "may",
"could", "should", "anticipates", "likely", "believes" and words of
similar import also identify forward-looking statements.
Forward-looking statements are based on current facts and analyses
and other information that are based on forecasts of future
results, estimates of amounts not yet determined and assumptions of
management. Readers are urged not to place undue reliance on the
forward-looking statements, which speak only as of the date of this
release. We assume no obligation to update any forward-looking
statements in order to reflect any event or circumstance that may
arise after the date of this release. Additional information on
risks and other factors that may affect the business and financial
results of NXT Nutritionals Holdings, Inc. can be found in the
filings of NXT Nutritionals Holdings, Inc. with the U.S. Securities
and Exchange Commission.
NXT Nutritionals (CE) (USOTC:NXTH)
Historical Stock Chart
From Dec 2024 to Jan 2025
NXT Nutritionals (CE) (USOTC:NXTH)
Historical Stock Chart
From Jan 2024 to Jan 2025